NCT01450982View on ClinicalTrials.gov

A Study to Investigate How JNJ-38518168 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2011

Study Completion Date

October 31, 2011

Conditions

Rheumatoid Arthritis

Interventions

DRUG

JNJ-38518168 / MTX

Day 1: MTX: Route=oral use, single dose of participant's weekly MTX dose

Trial Locations (4)

Unknown

Anniston

Daytona Beach

Duncansville

Dallas

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT01450982 - A Study to Investigate How JNJ-38518168 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants | Biotech Hunter | Biotech Hunter